Table of Contents
Chapter 1. Methodology and Scope
1.1. Information Procurement
1.2. Information Or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
1.4.1. Market Study, By Company Market Share
1.4.2. Regional Analysis
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Epigenetics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of cancer
3.2.1.2. Rise in number of geriatric patients
3.2.1.3. Expanding governmental initiatives in the epigenetics field
3.2.2. Market restraint analysis
3.2.2.1. Worries about diagnoses using epigenetics in terms of standardization
3.2.2.2. Lack of skilled professionals
3.2.3. Market opportunity analysis
3.2.3.1. Improvement in healthcare infrastructure in developing economies
3.3. Epigenetics Market Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Epigenetics Market: Product Movement Analysis
4.2. Reagents
4.2.1. Reagents Market, 2018 – 2030 (USD Million)
4.3. Kits
4.3.1. Kits Market, 2018 – 2030 (USD Million)
4.3.2. Chip Sequencing Kit
4.3.2.1. Chip sequencing kit Market, 2018 – 2030 (USD Million)
4.3.3. Whole Genomic Amplification kit
4.3.3.1. Whole Genomic Amplification Kit Market, 2018 – 2030 (USD Million)
4.3.4. Bisulfite Conversion Kit
4.3.4.1. Bisulfite Conversion Kit Market, 2018 – 2030 (USD Million)
4.3.5. RNA Sequencing Kit
4.3.5.1. RNA Sequencing Kit Market, 2018 – 2030 (USD Million)
4.3.6. Others
4.3.6.1. Others Market, 2018 – 2030 (USD Million)
4.4. Instruments
4.4.1. Instruments Market, 2018 – 2030 (USD Million)
4.5. Enzymes
4.5.1. Enzymes Market, 2018 – 2030 (USD Million)
4.6. Services
4.6.1. Services Market, 2018 – 2030 (USD Million)
Chapter 5. Application Business Analysis
5.1. Epigenetics Market: Application Movement Analysis
5.2. Oncology
5.2.1. Oncology Market, 2018 – 2030 (USD Million)
5.2.2. Solid Tumors
5.2.2.1. Solid Tumors Market, 2018 – 2030 (USD Million)
5.2.3. Others
5.2.3.1. Others Market, 2018 – 2030 (USD Million)
5.3. Non-oncology
5.3.1. Non-oncology Market, 2018 – 2030 (USD Million)
5.3.2. Inflammatory Diseases
5.3.2.1. Inflammatory Diseases Market, 2018 – 2030 (USD Million)
5.3.3. Metabolic Diseases
5.3.3.1. Metabolic Diseases Market, 2018 – 2030 (USD Million)
5.3.4. Infectious Diseases
5.3.4.1. Infectious Diseases Market, 2018 – 2030 (USD Million)
5.3.5. Cardiovascular Diseases
5.3.5.1. Cardiovascular Diseases Market, 2018 – 2030 (USD Million)
5.3.6. Others
5.3.6.1. Others Market, 2018 – 2030 (USD Million)
Chapter 6. Technology Business Analysis
6.1. Epigenetics Market: Technology Movement Analysis
6.2. DNA Methylation
6.2.1. DNA Methylation Market, 2018 – 2030 (USD Million)
6.3. Histone Methylation
6.3.1. Histone Methylation Market, 2018 – 2030 (USD Million)
6.4. Histone Acetylation
6.4.1. Histone Acetylation Market, 2018 – 2030 (USD Million)
6.5. Large Noncoding RNA
6.5.1. Large noncoding RNA Market, 2018 – 2030 (USD Million)
6.6. MicroRNA Modification
6.6.1. MicroRNA modification Market, 2018 – 2030 (USD Million)
6.7. Chromatin Structure
6.7.1. Chromatin Structure Market, 2018 – 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Epigenetics Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. SWOT Analysis
7.2.2. North America Epigenetics Market, 2018 – 2030 (USD Million)
7.2.3. U.S.
7.2.3.1. Key Country Dynamics
7.2.3.2. Target Disease Prevalence
7.2.3.3. Competitive Scenario
7.2.3.4. Regulatory Framework
7.2.3.5. Reimbursement Scenario
7.2.3.6. U.S. Epigenetics Market, 2018 – 2030 (USD Million)
7.2.4. Canada
7.2.4.1. Key Country Dynamics
7.2.4.2. Target Disease Prevalence
7.2.4.3. Competitive Scenario
7.2.4.4. Regulatory Framework
7.2.4.5. Reimbursement Scenario
7.2.4.6. Canada Epigenetics Market, 2018 – 2030 (USD Million)
7.3. Europe
7.3.1. SWOT Analysis
7.3.2. Europe Epigenetics Market, 2018 – 2030 (USD Million)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Regulatory Framework
7.3.3.5. Reimbursement Scenario
7.3.3.6. UK Epigenetics Market, 2018 – 2030 (USD Million)
7.3.4. Germany
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Regulatory Framework
7.3.4.5. Reimbursement Scenario
7.3.4.6. Germany Epigenetics Market, 2018 – 2030 (USD Million)
7.3.5. France
7.3.5.1. Key Country Dynamics
7.3.5.2. Target Disease Prevalence
7.3.5.3. Competitive Scenario
7.3.5.4. Regulatory Framework
7.3.5.5. Reimbursement Scenario
7.3.5.6. France Epigenetics Market, 2018 – 2030 (USD Million)
7.3.6. Italy
7.3.6.1. Key Country Dynamics
7.3.6.2. Target Disease Prevalence
7.3.6.3. Competitive Scenario
7.3.6.4. Regulatory Framework
7.3.6.5. Reimbursement Scenario
7.3.6.6. Italy Epigenetics Market, 2018 – 2030 (USD Million)
7.3.7. Spain
7.3.7.1. Key Country Dynamics
7.3.7.2. Target Disease Prevalence
7.3.7.3. Competitive Scenario
7.3.7.4. Regulatory Framework
7.3.7.5. Reimbursement Scenario
7.3.7.6. Spain Epigenetics Market, 2018 – 2030 (USD Million)
7.3.8. Denmark
7.3.8.1. Key Country Dynamics
7.3.8.2. Target Disease Prevalence
7.3.8.3. Competitive Scenario
7.3.8.4. Regulatory Framework
7.3.8.5. Reimbursement Scenario
7.3.8.6. Denmark Epigenetics Market, 2018 – 2030 (USD Million)
7.3.9. Sweden
7.3.9.1. Key Country Dynamics
7.3.9.2. Target Disease Prevalence
7.3.9.3. Competitive Scenario
7.3.9.4. Regulatory Framework
7.3.9.5. Reimbursement Scenario
7.3.9.6. Sweden Epigenetics Market, 2018 – 2030 (USD Million)
7.3.10. Norway
7.3.10.1. Key Country Dynamics
7.3.10.2. Target Disease Prevalence
7.3.10.3. Competitive Scenario
7.3.10.4. Regulatory Framework
7.3.10.5. Reimbursement Scenario
7.3.10.6. Norway Epigenetics Market, 2018 – 2030 (USD Million)
7.4. Asia Pacific
7.4.1. SWOT Analysis
7.4.2. Asia Pacific Epigenetics Market, 2018 – 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Regulatory Framework
7.4.3.5. Reimbursement Scenario
7.4.3.6. Japan Epigenetics Market, 2018 – 2030 (USD Million)
7.4.4. China
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. Regulatory Framework
7.4.4.5. Reimbursement Scenario
7.4.4.6. China Epigenetics Market, 2018 – 2030 (USD Million)
7.4.5. India
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Regulatory Framework
7.4.5.5. Reimbursement Scenario
7.4.5.6. India Epigenetics Market, 2018 – 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Regulatory Framework
7.4.6.5. Reimbursement Scenario
7.4.6.6. Australia Epigenetics Market, 2018 – 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Regulatory Framework
7.4.7.5. Reimbursement Scenario
7.4.7.6. Thailand Epigenetics Market, 2018 – 2030 (USD Million)
7.4.8. South Korea
7.4.8.1. Key Country Dynamics
7.4.8.2. Target Disease Prevalence
7.4.8.3. Competitive Scenario
7.4.8.4. Regulatory Framework
7.4.8.5. Reimbursement Scenario
7.4.8.6. South Korea Epigenetics Market, 2018 – 2030 (USD Million)
7.5. Latin America
7.5.1. SWOT Analysis
7.5.2. Latin America Epigenetics Market, 2018 – 2030 (USD Million)
7.5.3. Brazil
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Regulatory Framework
7.5.3.5. Reimbursement Scenario
7.5.3.6. Brazil Epigenetics Market, 2018 – 2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Regulatory Framework
7.5.4.5. Reimbursement Scenario
7.5.4.6. Mexico Epigenetics Market, 2018 – 2030 (USD Million)
7.5.5. Argentina
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Competitive Scenario
7.5.5.4. Regulatory Framework
7.5.5.5. Reimbursement Scenario
7.5.5.6. Argentina Epigenetics Market, 2018 – 2030 (USD Million)
7.6. MEA
7.6.1. SWOT Analysis
7.6.2. MEA Epigenetics Market, 2018 – 2030 (USD Million)
7.6.3. South Africa
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Regulatory Framework
7.6.3.5. Reimbursement Scenario
7.6.3.6. South Africa Epigenetics Market, 2018 – 2030 (USD Million)
7.6.4. Saudi Arabia
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. Regulatory Framework
7.6.4.5. Reimbursement Scenario
7.6.4.6. Saudi Arabia Epigenetics Market, 2018 – 2030 (USD Million)
7.6.5. UAE
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Competitive Scenario
7.6.5.4. Regulatory Framework
7.6.5.5. Reimbursement Scenario
7.6.5.6. UAE Epigenetics Market, 2018 – 2030 (USD Million)
7.6.6. Kuwait
7.6.6.1. Key Country Dynamics
7.6.6.2. Target Disease Prevalence
7.6.6.3. Competitive Scenario
7.6.6.4. Regulatory Framework
7.6.6.5. Reimbursement Scenario
7.6.6.6. Kuwait Epigenetics Market, 2018 – 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share Analysis, 2022
8.4. Company Profiles/Listing
8.4.1. Roche Diagnostics
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Type benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Thermo Fisher Scientific, Inc.
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Type benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Eisai Co. Ltd.
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Type benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Novartis AG
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Type benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Element Biosciences, Inc.
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Type benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Dovetail Genomics LLC.
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Type benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Illumina, Inc.
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Type benchmarking
8.4.7.4. Strategic initiatives
8.4.8. ValiRx Plc.
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Type benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Abcam plc.
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Type benchmarking
8.4.9.4. Strategic initiatives
Table 1 List of Abbreviation
Table 2 North America Epigenetics market, by country, 2018 - 2030 (USD Million)
Table 3 North America Epigenetics market, by product, 2018 - 2030 (USD Million)
Table 4 North America Epigenetics market, by application, 2018 - 2030 (USD Million)
Table 5 North America Epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 6 U.S. Epigenetics market, by product, 2018 - 2030 (USD Million)
Table 7 U.S. Epigenetics market, by application, 2018 - 2030 (USD Million)
Table 8 U.S. Epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 9 Canada Epigenetics market, by product, 2018 - 2030 (USD Million)
Table 10 Canada Epigenetics market, by application, 2018 - 2030 (USD Million)
Table 11 Canada Epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 12 Europe Epigenetics market, by country, 2018 - 2030 (USD Million)
Table 13 Europe Epigenetics market, by product, 2018 - 2030 (USD Million)
Table 14 Europe Epigenetics market, by application, 2018 - 2030 (USD Million)
Table 15 Europe Epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 16 UK Epigenetics market, by product, 2018 - 2030 (USD Million)
Table 17 UK Epigenetics market, by application, 2018 - 2030 (USD Million)
Table 18 UK Epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 19 Germany Epigenetics market, by product, 2018 - 2030 (USD Million)
Table 20 Germany Epigenetics market, by application, 2018 - 2030 (USD Million)
Table 21 Germany Epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 22 France Epigenetics market, by product, 2018 - 2030 (USD Million)
Table 23 France Epigenetics market, by application, 2018 - 2030 (USD Million)
Table 24 France Epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 25 Italy Epigenetics market, by product, 2018 - 2030 (USD Million)
Table 26 Italy Epigenetics market, by application, 2018 - 2030 (USD Million)
Table 27 Italy Epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 28 Spain Epigenetics market, by product, 2018 - 2030 (USD Million)
Table 29 Spain Epigenetics market, by application, 2018 - 2030 (USD Million)
Table 30 Spain Epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 31 Denmark Epigenetics market, by product, 2018 - 2030 (USD Million)
Table 32 Denmark Epigenetics market, by application, 2018 - 2030 (USD Million)
Table 33 Denmark Epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 34 Sweden Epigenetics market, by product, 2018 - 2030 (USD Million)
Table 35 Sweden Epigenetics market, by application, 2018 - 2030 (USD Million)
Table 36 Sweden Epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 37 Norway Epigenetics market, by product, 2018 - 2030 (USD Million)
Table 38 Norway Epigenetics market, by application, 2018 - 2030 (USD Million)
Table 39 Norway Epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 40 Asia Pacific Epigenetics market, by country, 2018 - 2030 (USD Million)
Table 41 Asia Pacific Epigenetics market, by product, 2018 - 2030 (USD Million)
Table 42 Asia Pacific Epigenetics market, by application, 2018 - 2030 (USD Million)
Table 43 Asia Pacific Epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 44 China Epigenetics market, by product, 2018 - 2030 (USD Million)
Table 45 China Epigenetics market, by application, 2018 - 2030 (USD Million)
Table 46 China Epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 47 Japan Epigenetics market, by product, 2018 - 2030 (USD Million)
Table 48 Japan Epigenetics market, by application, 2018 - 2030 (USD Million)
Table 49 Japan Epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 50 India Epigenetics market, by product, 2018 - 2030 (USD Million)
Table 51 India Epigenetics market, by application, 2018 - 2030 (USD Million)
Table 52 India Epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 53 Australia Epigenetics market, by product, 2018 - 2030 (USD Million)
Table 54 Australia Epigenetics market, by application, 2018 - 2030 (USD Million)
Table 55 Australia Epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 56 South Korea Epigenetics market, by product, 2018 - 2030 (USD Million)
Table 57 South Korea Epigenetics market, by application, 2018 - 2030 (USD Million)
Table 58 South Korea Epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 59 Thailand Epigenetics market, by product, 2018 - 2030 (USD Million)
Table 60 Thailand Epigenetics market, by application, 2018 - 2030 (USD Million)
Table 61 Thailand Epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 62 Latin America Epigenetics market, by country, 2018 - 2030 (USD Million)
Table 63 Latin America Epigenetics market, by product, 2018 - 2030 (USD Million)
Table 64 Latin America Epigenetics market, by application, 2018 - 2030 (USD Million)
Table 65 Latin America Epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 66 Brazil Epigenetics market, by product, 2018 - 2030 (USD Million)
Table 67 Brazil Epigenetics market, by application, 2018 - 2030 (USD Million)
Table 68 Brazil Epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 69 Mexico Epigenetics market, by product, 2018 - 2030 (USD Million)
Table 70 Mexico Epigenetics market, by application, 2018 - 2030 (USD Million)
Table 71 Mexico Epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 72 Argentina Epigenetics market, by product, 2018 - 2030 (USD Million)
Table 73 Argentina Epigenetics market, by application, 2018 - 2030 (USD Million)
Table 74 Argentina Epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 75 Middle East and Africa Epigenetics market, by country, 2018 - 2030 (USD Million)
Table 76 Middle East and Africa Epigenetics market, by product, 2018 - 2030 (USD Million)
Table 77 Middle East and Africa Epigenetics market, by application, 2018 - 2030 (USD Million)
Table 78 Middle East and Africa Epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 79 South Africa Epigenetics market, by product, 2018 - 2030 (USD Million)
Table 80 South Africa Epigenetics market, by application, 2018 - 2030 (USD Million)
Table 81 South Africa Epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia Epigenetics market, by product, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia Epigenetics market, by application, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia Epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 85 UAE Epigenetics market, by product, 2018 - 2030 (USD Million)
Table 86 UAE Epigenetics market, by application, 2018 - 2030 (USD Million)
Table 87 UAE Epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 88 Kuwait Epigenetics market, by product, 2018 - 2030 (USD Million)
Table 89 Kuwait Epigenetics market, by application, 2018 - 2030 (USD Million)
Table 90 Kuwait Epigenetics market, by technology, 2018 - 2030 (USD Million)
